Salesforce stock is down around 28% this year amid a broad tech sell-off and concerns about AI disruption in the... The first patient has been dosed with Mahzi Therapeutics' potential gene-therapy fix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results